Osbro Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 2.00 Cr
- Revenue Growth -10.89%
- Profit Growth 89.19%
- Ebitda 1308.58%
- Net Worth -1.47%
- Total Assets 3.42%
About Osbro Pharmaceutical
Osbro Pharmaceutical Private Limited (OPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 October 2013 and has a history of 11 years and three months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110PN2013PTC149114
-
Company No.
149114
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Oct 2013
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Osbro Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Agrawal
|
Director | 29-May-2016 | Current |
|
Amit Mehta
|
Director | 29-May-2016 | Current |
|
Manoj Golawar
|
Director | 29-May-2016 | Current |
|
Bharat Oswal
|
Director | 11-Oct-2013 | Current |
Financial Performance of Osbro Pharmaceutical.
Osbro Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.89% decrease. The company also saw a substantial improvement in profitability, with a 89.19% increase in profit. The company's net worth dipped by a decrease of 1.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Osbro Pharmaceutical?
In 2022, Osbro Pharmaceutical had a promoter holding of 31.45% and a public holding of 68.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gc Pharma Remedies Private LimitedGopal Agrawal is a mutual person
-
Mas Healthcare Private Limited
Amit Mehta and Manoj Golawar are mutual person
-
Medvin Lifesciences Private Limited
Amit Mehta and Manoj Golawar are mutual person
-
Agt Energies Private Limited
Manoj Golawar is a mutual person
-
United Uprise Lifespaces Llp
Bharat Oswal is a mutual person
-
Zirconia Ventures Llp
Bharat Oswal is a mutual person
Charges (Loans)
₹0
₹20.00 M
Charges Breakdown by Lending Institutions
- Others : 1.50 Cr
- Lonavala Sahakari Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2014 | Lonavala Sahakari Bank Limited | ₹5.00 M | Satisfied |
| 31 Oct 2014 | Others | ₹1.50 Cr | Satisfied |
How Many Employees Work at Osbro Pharmaceutical?
Osbro Pharmaceutical has a workforce of 2 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Osbro Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osbro Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
